Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

Hiddo J.L. Heerspink(University Medical Center Groningen), Philip Kam‐Tao Li(Hospital Authority), Willem Collier(University of Utah), Tom Greene(University Medical Center Groningen), Christoph Wanner(Universitätsklinikum Würzburg), Raymond O. Estacio(Denver Health Medical Center), Benjamin Haaland(University of Utah), Manuel Praga(Universidad Complutense de Madrid), Annalisa Perna(Mario Negri Institute for Pharmacological Research), Lesley A. Inker(Tufts Medical Center), Julia B. Lewis, Hocine Tighiouart(Tufts University), Tak Mao Chan(Chinese University of Hong Kong), Francesco Locatelli(University of Modena and Reggio Emilia), Fernando C. Fervenza(Mayo Clinic), Enyu Imai(Takara (Japan)), Jiyu Luo(University of California San Diego), Bart Maes(AZ Delta), Ronald D. Perrone(Tufts Medical Center), Tazeen H. Jafar(Apple (Israel)), Francesco Paolo Schena(University of Bari Aldo Moro), Di Xie(Nanfang Hospital), Jürgen Floege(RWTH Aachen University), Gerald B. Appel(Columbia University Irving Medical Center)
Journal of the American Society of Nephrology
March 15, 2023
Cited by 25


Related Papers